Not recruiting
Acute myeloid leukaemia
Not recruitingStudy of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation
Registered drugNo placebo
Study of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation
Registered drugNo placebo
- Disease:Acute myeloid leukaemia
- Substances:CytarabineDaunorubicin+2
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Cytarabine
